Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis

Summary

RATIONALE: Drugs used in chemotherapy, such as decitabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying the side effects and how well low-dose decitabine works in treating patients with symptomatic myelofibrosis.

Timeline

Start

2008-03

Primary completion

2009-08

Completion

2012-04

Outcome

Outcome not reported

Stopped (Enrollment): “Stopped due to slow accrual”

Drugs

Indications